530125 Stock Overview
Engages in the manufacture and sale of pharmaceutical chemicals in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Samrat Pharmachem Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹463.30 |
| 52 Week High | ₹646.00 |
| 52 Week Low | ₹320.00 |
| Beta | 0.27 |
| 11 Month Change | -9.01% |
| 3 Month Change | 15.22% |
| 1 Year Change | 25.78% |
| 33 Year Change | 95.40% |
| 5 Year Change | 398.71% |
| Change since IPO | 9,166.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 530125 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -4.8% | -2.1% | -1.8% |
| 1Y | 25.8% | 11.3% | 27.2% |
Return vs Industry: 530125 exceeded the Indian Chemicals industry which returned 11.1% over the past year.
Return vs Market: 530125 underperformed the Indian Market which returned 27% over the past year.
Price Volatility
| 530125 volatility | |
|---|---|
| 530125 Average Weekly Movement | 8.9% |
| Chemicals Industry Average Movement | 5.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 530125's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 530125's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 32 | Lalit Mehta | www.samratpharmachem.com |
Samrat Pharmachem Limited engages in the manufacture and sale of pharmaceutical chemicals in India. It offers 3-5-di iodosalicylic acid, ammonium iodide, cadmium iodide, calcium iodate, clioquinol, copper iodide, ethyl iodide, ethylenediamine dihydroiodide, hydroiodic acid, iodic acid, iodine, iodine monochloride, iodoquinol, lithium iodide, methyl iodide, n-iodo succinimide, periodic acid, potassium iodate, potassium iodide, potassium metaper iodate, povidone iodine, selenium dioxide, sodium iodate, sodium iodide, sodium metaper iodate, sodium selenite, and tri methyl sulphoxonium iodide. The company serves agrochemical, animal feed, chemical, cosmetics, food, LCD screen, contrast media, pharmaceutical, screen printing, nylon textile, and tire cord manufacturing industries.
Samrat Pharmachem Limited Fundamentals Summary
| 530125 fundamental statistics | |
|---|---|
| Market cap | ₹1.43b |
| Earnings (TTM) | ₹64.66m |
| Revenue (TTM) | ₹2.96b |
22.1x
P/E Ratio0.5x
P/S RatioIs 530125 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 530125 income statement (TTM) | |
|---|---|
| Revenue | ₹2.96b |
| Cost of Revenue | ₹2.79b |
| Gross Profit | ₹164.83m |
| Other Expenses | ₹100.16m |
| Earnings | ₹64.66m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 20.93 |
| Gross Margin | 5.57% |
| Net Profit Margin | 2.19% |
| Debt/Equity Ratio | 13.2% |
How did 530125 perform over the long term?
See historical performance and comparison